Quick Answer
TriSalus Life Sciences, Inc. reported Shares Outstanding of 50.00 million shares for fiscal year 2025.
TriSalus Life Sciences, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 50.00M | +59.8% |
| 2024 | 31.28M | +18.4% |
| 2023 | 26.41M | +0.4% |
| 2023 | 26.32M | +7463.9% |
| 2022 | 347,926 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 49.89M | +63.7% | +31.4% |
| June 30, 2025 | 37.98M | +39.9% | +17.7% |
| March 31, 2025 | 32.27M | +20.6% | +3.2% |
| December 31, 2024 | 31.28M | +18.4% | +2.7% |
| September 30, 2024 | 30.47M | +15.8% | +12.2% |
| June 30, 2024 | 27.16M | — | +1.5% |
| March 31, 2024 | 26.76M | — | +1.3% |
| December 31, 2023 | 26.41M | +7491.6% | +0.4% |
- TriSalus Life Sciences, Inc. showed an increase of +59.8% in Shares Outstanding compared to the prior fiscal year.
- Over the 2022–2025 period, TriSalus Life Sciences, Inc.’s shares outstanding has grown by 14270.2% (from 347.9 thousand shares to 50.00 million shares).
- The most recent figure is from TriSalus Life Sciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: